Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 296-301

  Marcos, Amadeo ^a   Ham, John M ^a   Fisher, Robert A ^a   Olzinski, Ann T ^a   Posner, Marc P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LIVING DONOR; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; STENT;

EID: 0034113015     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/lv.2000.6354     Document Type: Article

References (17)

1. Marcos A, Fisher R, Ham J, Shiffman M, Sanyal A, Luketic V, et al. Right lobe living donor liver transplantation. Transplantation 1999;68:798-803.
2. Marcos A, Fisher R, Ham J, Shiffman M, Sanyal A, Luketic V, et al. Liver regeneration and function in donor and recipient after right lobe adult-to-adult liver transplantation. Transplantation 2000 (in press).
3. Marcos A, Fisher R, Ham J, Olzinski A, Shiffman M, Sanyal A, et al. Emergency portacaval shunt for control of hemorrhage from a parenchymal fracture following adult-to-adult living donor liver transplantation. Transplantation 2000 (in press).
4. Lo C, Fan S, Liu C, Wei W, Lo R, Lai C, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997;226:261-270.
5. Yamaoka Y, Morimoto T, Inamoto T, Tanaka A, Honda K, Ikai I, et al. Safety of the donor in living-related liver transplantation - An analysis of 100 parental donors. Transplantation 1995;59:224-226.
6. Rogiers C, Malago M, Nollkemper D, Sterneck M, Burdelski M, Broelsch C. The Hamburg liver transplant program. Clin Transpl 1997;183-190.
7. Bakalakos E, Kim J, Young D, Martin E. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 1998;22:399-404.
8. Grewal H, Thistlethwaite J, Loss G, Fisher J, Cronin D, Siegel C, et al. Complications in 100 living liver donors. Ann Surg 1998;228:214-219.
9. Sterneck M, Nischwitz U, Fischer L, Malago M, Rogiers X, Raedler A, et al. Evaluation and morbidity of the living liver donor in pediatric liver transplantation. Transplant Proc 1995; 27:1164-1165.
10. Seaberg E, Belle S, Beringer K, Schivins J, Detre K. Long-term patient and retransplantation-free survival by selected recipient and donor characteristics: An update from the Pitt-UNOS Liver Transplant Registry. Clin Transpl 1997;15-28.
11. Shakil A, Mazariegos G, Kramer D. Fulminant hepatic failure. Surg Clin North Am 1999;79:77-108.
12. Reichert P, Renz J, Rosenthal P, Baccchetti P, Lim R, Roberts J, et al. Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg 1998;4:343-349.
13. Cronin D, Alonso E, Piper J, Newell K, Bruce D, Woodle E, et al. Biliary complications in living donor liver transplantation. Transplant Proc 1997;29:419-420.
14. Seiler C. The bile duct anastomosis in liver transplantation. Dig Surg 1999;16:102-106.
15. Nueberger J. Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg 1999;5(suppl 1):S30-S36.
16. Jonas S, Kling N, Bechstein W, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Rejection episodes after liver transplanta-tion during primary immunosuppression with FK506 or a cyclosporine-based regimen: A controlled, prospective, randomized trial. Clin Transplant 1995;9:406-414.
17. Fisher R, Ham J, Marcos A, Shiffman M, Luketic V, Kimball P, et al. A prospective randomized trial of mycophenolate mofetil with Neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998;66:1616-1621.